Maintenance rituximab should be considered for patients with follicular lymphoma. [electronic resource]
Producer: 20150820Description: 541-3 p. digitalISSN:- 1543-0790
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cost-Benefit Analysis
- Disease Progression
- Humans
- Lymphoma, Follicular -- drug therapy
- Maintenance Chemotherapy
- Quality of Life
- Rituximab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.